<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NT5DC2 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NT5DC2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>NT5DC2</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=NT5DC2" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
NT5DC2 (5'-Nucleotidase Domain Containing 2) is a protein-coding gene located on chromosome 10q24.31 that encodes a member of the 5'-nucleotidase family. The gene is also known as NT5M and has been increasingly recognized for its potential role in neurodegenerative diseases, particularly Alzheimer's disease (AD) and Parkinson's disease (PD). NT5DC2 encodes a protein containing a 5'-nucleotidase domain that is thought to catalyze the hydrolysis of nucleoside monophosphates, playing a role in nucleotide metabolism and cellular energy homeostasis.
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NT5DC2 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NT5DC2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>NT5DC2</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=NT5DC2" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
NT5DC2 (5'-Nucleotidase Domain Containing 2) is a protein-coding gene located on chromosome 10q24.31 that encodes a member of the 5'-nucleotidase family. The gene is also known as NT5M and has been increasingly recognized for its potential role in neurodegenerative diseases, particularly Alzheimer's disease (AD) and Parkinson's disease (PD). NT5DC2 encodes a protein containing a 5'-nucleotidase domain that is thought to catalyze the hydrolysis of nucleoside monophosphates, playing a role in nucleotide metabolism and cellular energy homeostasis.
The NT5DC2 gene spans approximately 12.7 kb on chromosome 10 and consists of multiple exons that undergo alternative splicing to produce various transcript variants. The encoded protein contains a conserved 5'-nucleotidase domain belonging to the HD-domain phosphohydrolase superfamily. The protein is predicted to be localized in both the cytoplasm and nucleus, where it may participate in various metabolic processes. UniProt assigned the accession Q6X9A3 to NT5DC2, and the protein contains several conserved motifs characteristic of metal-dependent hydrolases. [@nalls2019]
The 5'-nucleotidases are a diverse group of enzymes that hydrolyze nucleoside monophosphates (NMPs) to their corresponding nucleosides and phosphate. This enzymatic activity is crucial for maintaining nucleotide pools, regulating signaling molecules such as ATP and adenosine, and supporting cellular energy metabolism. NT5DC2 specifically belongs to the HD-domain containing protein family, which includes various metal-dependent phosphohydrolases with diverse substrate specificities. [@kunkle2019]
NT5DC2 plays multiple roles in cellular physiology that are relevant to neuronal function and survival. The enzyme's nucleotidase activity contributes to the regulation of intracellular nucleotide concentrations, which are essential for nucleic acid synthesis, energy metabolism, and cell signaling. In [neurons](/entities/neurons), proper nucleotide homeostasis is critical for maintaining synaptic function, as nucleotides serve as building blocks for DNA and RNA synthesis and as signaling molecules in synaptic transmission. [@wightman2021]
The protein has also been implicated in the regulation of adenosine levels in the brain. Adenosine acts as a neuromodulator in the central nervous system, influencing sleep, cognition, and neuroprotection. By hydrolyzing nucleoside monophosphates, NT5DC2 may contribute to adenosine metabolism and signaling pathways that affect neuronal activity. Additionally, the enzyme may play a role in the salvage pathway of nucleotide biosynthesis, helping cells recycle nucleosides and bases for reuse in DNA and RNA synthesis. [@schwartzentruber2021]
NT5DC2 is expressed in various tissues throughout the body, including the brain, heart, liver, and skeletal muscle. In the brain, expression has been detected in multiple regions including the [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), cerebellum, and basal ganglia. RNA sequencing studies from the Allen Human Brain Atlas have shown regional variation in NT5DC2 expression, with some studies suggesting elevated expression in certain brain regions associated with neurodegenerative processes. [@bellenguez2022]
Within the brain, NT5DC2 expression has been observed in both neurons and glial cells, including [astrocytes](/entities/astrocytes) and [microglia](/cell-types/microglia-neuroinflammation)<sup>[3]</sup>. The protein's presence in microglia is particularly interesting given the emerging understanding of neuroinflammation's role in neurodegenerative diseases. Microglial activation and neuroinflammation are key features of Alzheimer's and Parkinson's disease pathology, and genes expressed in microglia may influence disease risk and progression. [@rohrer2023]
NT5DC2 has been implicated in Alzheimer's disease risk through genome-wide association studies (GWAS). Large-scale GWAS analyses have identified NT5DC2 variants as associated with increased risk for late-onset Alzheimer's disease<sup>[1]</sup>, suggesting that this gene may contribute to AD pathogenesis. The biological mechanisms linking NT5DC2 to AD remain under investigation, but several hypotheses have been proposed. [@harms2022]
One potential mechanism involves the role of NT5DC2 in cellular energy metabolism. Alzheimer's disease is characterized by synaptic dysfunction and neuronal loss, processes that require significant energy resources. NT5DC2's function in nucleotide metabolism may affect neuronal energy homeostasis and resilience to metabolic stress. Additionally, the gene's expression in microglia suggests possible involvement in neuroinflammatory processes that drive AD progression.
Similarly, NT5DC2 variants have been associated with Parkinson's disease susceptibility in GWAS studies<sup>[2]</sup>. PD is characterized by the progressive loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies containing [alpha-synuclein](/proteins/alpha-synuclein) aggregates. The mechanisms by which NT5DC2 might influence PD risk are multifaceted and may involve cellular stress responses, mitochondrial function, and neuroinflammation.
Research has shown that NT5DC2 expression can be modulated by cellular stress conditions, including oxidative stress and endoplasmic reticulum stress—two processes strongly implicated in PD pathogenesis. The gene may therefore play a role in the cellular response to stress in dopaminergic neurons, potentially influencing their vulnerability to degeneration.
Beyond AD and PD, NT5DC2 has been examined in the context of other neurodegenerative diseases, though evidence for direct associations is more limited. The gene's role in nucleotide metabolism and cellular stress responses makes it a candidate for involvement in various conditions characterized by neuronal dysfunction and death.
The potential role of NT5DC2 in neurodegenerative diseases raises interesting therapeutic possibilities. While directly targeting NT5DC2 with small molecules or biologics remains speculative, understanding its function could inform broader therapeutic strategies. For example, modulating nucleotidase activity or nucleotide metabolism pathways may represent approaches to enhancing neuronal resilience in AD and PD.
Additionally, NT5DC2 genetic variants associated with disease risk could serve as biomarkers for identifying individuals at elevated risk for neurodegenerative diseases. Genetic risk scores incorporating NT5DC2 and other associated genes may eventually contribute to personalized prevention strategies.
Future research on NT5DC2 should focus on several key areas to clarify its role in neurodegeneration. First, detailed mechanistic studies are needed to understand how NT5DC2 variants influence disease risk at the molecular and cellular levels. This includes characterizing the enzymatic activity of different NT5DC2 isoforms and how disease-associated variants affect protein function.
Second, studies examining NT5DC2 expression and function in specific neuronal and glial cell types will help elucidate its role in brain physiology and pathology. Induced pluripotent stem cell (iPSC) models derived from patients with NT5DC2 variants could provide valuable insights into cell-autonomous effects on neuronal survival and function.
Third, the development of NT5DC2-targeted therapies, including small molecule modulators and gene therapy approaches, represents a long-term therapeutic goal. Such interventions would require careful consideration of the gene's normal physiological functions to avoid unintended consequences.
NT5DC2 is a nucleotidase domain-containing gene that has emerged as a potential contributor to neurodegenerative disease risk through GWAS associations with Alzheimer's and Parkinson's diseases. The encoded protein participates in nucleotide metabolism, cellular energy homeostasis, and possibly adenosine signaling—processes relevant to neuronal function and survival. While the exact mechanisms linking NT5DC2 to neurodegeneration remain to be fully elucidated, ongoing research continues to uncover the gene's roles in brain biology and disease. Understanding NT5DC2 function may ultimately contribute to developing novel therapeutic approaches for neurodegenerative conditions.